Objective: To study the significance of c-myc and c-erbB-2 oncogene expression in gastric cancer. Methods: 81 gastric cancer specimens were detected for c-myc and c-erbB-2 oncogene amplification using non-radioactive in situ hybridization method. Results: The amplification rates for c-myc and c-erbB-2 were 67.9% and 50.6% respectively, and there were significant correlation in the amplification of these two genes (χ2 = 7.26, P < 0.01). Conclusions: The amplification of c-myc and c-erbB-2 may play an important role in gastric cancer development, and these two genes may have synergistic effect.
Knudsen, E.S., McClendon, A.K., Franco, J., Ertel, A., Fortina, P. and Witkiewicz, A.K. (2015) RB Loss Contributes to Aggressive Tumor Phenotypes in MYC-Driven Triple Negative Breast Cancer. Cell Cycle, 14, 109-122.
https://doi.org/10.4161/15384101.2014.967118
Tang, B., Xie, R., Qin, Y., Xiao, Y.F., Yong, X., Zheng, L., Dong, H. and Yang, S.M. (2016) Human Telomerase Reverse Transcriptase (hTERT) Promotes Gastric Cancer Invasion through Cooperating with c-Myc to Upregulate Heparanase Expression. Oncotarget, 7, 11364-11379. https://doi.org/10.18632/oncotarget.6575
Ishii, H.H., Gobé, G.C., Pan, W., Yoneyama, J. and Ebihara, Y. (2002) Apoptosis and Cell Proliferation in the Development of Gastric Carcinomas: Associations with c-myc and p53 Protein Expression. Journal of Gastroenterology and Hepatology, 17, 966-972. https://doi.org/10.1046/j.1440-1746.2002.02805.x
Xie, D., Sham, J.S., Zeng, W.F., Lin, H.L., Che, L.H., Wu, H.X., Wen, J.M., Fang, Y., Hu, L. and Guan, X.Y. (2003) Heterogeneous Expression and Association of Beta-Catenin, p16 and c-myc in Multistage Colorectal Tumorigenesis and Progression Detected By Tissue Microarray. International Journal of Cancer, 107, 896-902.
https://doi.org/10.1002/ijc.11514
Li, F.L., Deng, H., Wang, H.W., Xu, R., Chen, J., Wang, Y.F., Li, X., Fan, B. and Li, B. (2011) Effects of External Application of Chinese Mcdicine on Diabetic Ulcers and the Expressions of β-Catenin,c-myc and K6. Chinese Journal of Integrative Medicine, 17, 261-266. https://doi.org/10.1007/s11655-011-0703-5
Albihn, A., Johnsen, J.I. and Henriksson, M.A. (2010) MYC in Oncogenesis and as a Target for Cancer Therapies. Advances in Cancer Research, 107, 163-224.
https://doi.org/10.1016/S0065-230X(10)07006-5
Skvortsova, I., Skvortsov, S., Raju, U., Stasyk, T., Riesterer, O., Schottdorf, E.M., Popper, B.A., Schiestl, B., Eichberger, P., Debbage, P., Neher, A., Bonn, G.K., Huber, L.A., Milas, L. and Lukas, P. (2010) Epithelial-to-Mesenchymal Transition and c-myc Edpression Are the Detemninants of Cetuximab-Induced Enhancement of Squamous Cell Carcinoma Radioresponse. Radiotherapy and Oncology, 96, 108-115. https://doi.org/10.1016/j.radonc.2010.04.017
Lupu, R., Colomer, R., Kannan, B. and Lippman, M.E. (1992) Characterization of a Growth Factor that Binds Exclusively to the erbB-2 Receptor and Induces Cellular Responses. Proceedings of the National Academy of Sciences of the United States of America, 89, 2287-2291. https://doi.org/10.1073/pnas.89.6.2287
Lordick, F., Al-Batran, S.E., Dietel, M., Gaiser, T., Hofheinz, R.D., Kirchner, T., Kreipe, H.H., Lorenzen, S., M?hler, M., Quaas, A., R?cken, C., Rüschoff, J., Tannapfel, A., Thuss-Patience, P. and Baretton, G. (2017) HER2 Testing in Gastric Cancer: Results of a German Expert Meeting. Journal of Cancer Research and Clinical Oncology, 143, 835-841. https://doi.org/10.1007/s00432-017-2374-x
Hurvitz, S.A., Gelmon, K.A. and Tolaney, S.M. (2017) Optimal Management of Early and Advanced HER2 Breast Cancer. American Society of Clinical Oncology Educational Book, 37, 76-92. https://doi.org/10.14694/EDBK_175630
Bhaumik, S., Ahmad, F. and Das, B.R. (2016) Somatic Mutation Analysis of KRAS, BRAF, HER2 and PTEN in EGFR Mutation-Negative Non-Small Cell Lung Carcinoma: Determination of Frequency, Distribution Pattern and Identification of novel Deletion in HER2 Gene from Indian Patients. Medical Oncology, 33, 117.
https://doi.org/10.1007/s12032-016-0828-7
Murray, N.P., Reyes, E., Fuentealba, C., Jacob, O. and Orellana, N. (2015) Possible Role of HER-2 in the Progression of Prostate Cancer from Primary Tumor to Androgen Independence. Asian Pacific Journal of Cancer Prevention, 16, 6615-6619.
https://doi.org/10.7314/APJCP.2015.16.15.6615
Fanotto, V., Ongaro, E., Rihawi, K., Avallone, A., Silvestris, N., Fornaro, L., Vasile, E., Antonuzzo, L., Leone, F., Rosati, G., Giuliani, F., Bordonaro, R., Scartozzi, M., De Maglio, G., Negri, F.V., Fasola, G. and Aprile, G. (201) HER-2 Inhibition in Gastric and Colorectal Cancers: Tangible Achievements, Novel Acquisitions and Future Perspectives. Oncotarget, 7, 69060-69074.
https://doi.org/10.18632/oncotarget.11264
Wang, K., Liu, J., Duan, Y., Wu, J., Dongye, S., Wang, Y., Liu, Z. and Han, G. (2017) C-erbB-2 Expression Is Related with Pathological Progression of Gastric Cancer: Results of a Non-Radioactive in situ Hybridization. International Journal of Clinical and Experimental Pathology, 10, 9649-9653.
Houldsworth, J., Cordon-Cardo, C., Ladanyi, M., Kelsen, D.P. and Chaganti, R.S. (1990) Gene Amplification in Gastric and Esophaged Adenocarcinomas. Cancer Research, 50, 6417-6422.
Mizutani, T., Onda, M. and Tokunaga, A. (1993) Relationship of c-erbB-2 Protein Expression and Gene Amplification to Invasion and Metastasis in Human Gastric Cancer. Cancer, 72, 2083-2085.
https://doi.org/10.1002/1097-0142(19931001)72:7<2083::AID-CNCR2820720705>3.0.CO;2-1
